1211584

AstraZeneca Pharmaceuticals, LP — FEI 2517100

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 19, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Newark, DE (United States)